BriaCell Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is August - July.

Millions CAD. Fiscal year is Aug - Jul.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 13, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021
Market Capitalization	44	18	19	140	130	98
Market Cap Growth	104.88%	-5.88%	-86.55%	7.66%	32.65%	1321.84%
Enterprise Value	3	-0	17	102	73	73
Last Close Price	6.09	10.10	154.50	1314.00	1257.00	963.00
PB Ratio	1.08	0.74	-5.08	-28.18	9.82	2.84
P/TBV Ratio	1.06	0.72	-	-	10.05	2.87
Debt / Equity Ratio	-	-	-	-	-	0.00
Net Debt / Equity Ratio	-0.99	-1.03	0.32	5.63	-3.97	-2.07
Net Debt / EBITDA Ratio	0.98	0.66	0.03	0.91	2.69	8.22
Net Debt / FCF Ratio	0.97	0.63	0.04	0.90	3.29	7.39
Quick Ratio	9.39	4.49	0.21	11.80	43.64	102.88
Current Ratio	10.10	5.01	0.49	14.96	45.00	103.81
Return on Equity (ROE)	-179.21%	-362.56%	-	-619.75%	-141.25%	-114.78%
Return on Assets (ROA)	-89.44%	-123.56%	-126.11%	-41.71%	-18.99%	-14.89%
Return on Capital Employed (ROCE)	-101.10%	-153.90%	2097.70%	-91.80%	-36.70%	-12.10%
Earnings Yield	-91.04%	-205.42%	-35.14%	-19.08%	-26.45%	-17.58%
FCF Yield	-	-219.93%	-180.31%	-22.31%	-12.30%	-9.86%
Buyback Yield / Dilution	-784.70%	-285.70%	-5.35%	-0.81%	-242.82%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.